EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic Vulnerability Index predicts mortality in older adults based on markers of inflammation and dysmetabolism

Margery A. Connelly, Irina Shalaurova, Leanna M. Ross, Robin P. F. Dullaart, William E. Kraus, Virginia Byers Kraus

PLOS Aging and Health · 2026

DOI: 10.1371/journal.page.0000018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Aging and Health, 2026. Verfasst von Margery A. Connelly und 5 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association, National Institute on Aging.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional clinical metrics fail to capture the complex interplay among metabolic health, inflammation, and nutritional status contributing to aging-related morbidity and mortality. The Metabolic Vulnerability Index (MVX) integrates measures of inflammation and metabolic health to assess mortality risk. Using clinical nuclear magnetic resonance spectra and a validated MVX algorithm, MVX scores were generated for the Duke Established Populations for Epidemiologic Studies of the Elderly (D-EPESE) longitudinal cohort (n = 1507, mean age 78.1 ± 5.4 years; 36% men). MVX comprises markers of chronic inflammation (small high density lipoproteins and the inflammation marker, GlycA) and metabolic malnutrition (citrate and branched chain amino acids). Incident all-cause deaths were ascertained over a median follow-up of 7.0 years (95% confidence interval (CI):1.0–18.9). In models adjusted for age, sex, and race, greater MVX scores were strongly associated with 1-year mortality [hazard ratio (HR) per 1 standard (SD): 3.00 (CI: 2.34–3.85, p < 0.0001)]. After further adjustment for body mass index, type 2 diabetes, smoking, systolic blood pressure, total cholesterol, triglycerides, eGFR, and qualitative measures of health and physical function, the association persisted, with only modest attenuation [HR: 2.35 (CI: 1.76–3.14, p < 0.0001)]. Similar associations were observed for 2-, 5- and 10-year mortality, with some attenuation over longer follow-up. Participants in the greatest MVX quartile had significantly greater mortality risk (Kaplan-Meier, p < 0.0001). The 1-year AUROC for mortality was 0.77 (CI: 0.71–0.84), outperforming questionnaire-based measures of health and physical function, as well as the individual MVX components (p < 0.0001). Our findings suggest that MVX is a prognostic, biomarker-derived test that integrates markers of inflammation, metabolic dysfunction, and malnutrition to predict short- and long-term mortality in adults >70 years. MVX may provide additional clinical information to support personalized risk stratification and guide targeted approaches for older adults.

Förderung

  • American Heart Association
  • National Institute on Aging

Zitieren

APA

Connelly, M. A., Shalaurova, I., Ross, L. M., Dullaart, R. P. F., Kraus, W. E., & Kraus, V. B. (2026). Metabolic Vulnerability Index predicts mortality in older adults based on markers of inflammation and dysmetabolism. PLOS Aging and Health. https://doi.org/10.1371/journal.page.0000018

Vancouver

Connelly MA, Shalaurova I, Ross LM, Dullaart RPF, Kraus WE, Kraus VB. Metabolic Vulnerability Index predicts mortality in older adults based on markers of inflammation and dysmetabolism. PLOS Aging and Health. 2026. doi:10.1371/journal.page.0000018

BibTeX
@article{Connelly2026,
  author = {Connelly, Margery A. and Shalaurova, Irina and Ross, Leanna M. and Dullaart, Robin P. F. and Kraus, William E. and Kraus, Virginia Byers},
  title = {Metabolic Vulnerability Index predicts mortality in older adults based on markers of inflammation and dysmetabolism},
  journal = {PLOS Aging and Health},
  year = {2026},
  doi = {10.1371/journal.page.0000018}
}
Kostenlos starten →